Intellia Therapeutics' CRISPR treatment reduces hereditary angioedema attacks by 98%, showcasing potential of gene editing in treating complex diseases.
Researchers are pursuing gene integration to boost protein production, with challenges like developing precise editing tools being a focus.
RNA editing emerges as a frontier, enabling significant edits while keeping the patient's DNA unchanged.
[
add
]
[
|
|
...
]